IBL HealthCare Limited

IBLHL

PK0095501018

Drug Retailers

End-of-day quote Pakistan S.E. Other stock markets 06:00:00 2024-05-12 pm EDT			5-day change	1st Jan Change
34.77 ^PKR	-0.26%		+11.66%	-4.00%

Apr. 29	IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
Apr. 26	IBL Healthcare Limited Announces CEO Changes	CI

Ibl Healthcare Limited Appoints Munis Abdullah and Mobeen Alam as Non-Executive Directors

March 01, 2021 at 02:34 pm EST

IBL Healthcare Limited announced that Mr. Munis Abdullah and Mr. Mobeen Alam has been appointed as Non-Executive Directors with effect from February 24, 2021 in place of Mr. Rashid Abdullah and Mr. Shahid Abdullah.

Latest news about IBL HealthCare Limited

IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	Apr. 29	CI
IBL Healthcare Limited Announces CEO Changes	Apr. 25	CI
IBL Healthcare Limited Announces Board Changes	Apr. 25	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 29	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 01	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-06	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-06	CI
IBL HealthCare Limited Announces Executive Changes	23-09-26	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-02	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-03-01	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	22-10-27	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-28	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-04-27	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-02-28	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	21-10-25	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-04-29	CI
Ibl Healthcare Limited Appoints Munis Abdullah and Mobeen Alam as Non-Executive Directors	21-03-01	CI
Ibl Healthcare Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	21-03-01	CI
IBL HealthCare Limited Proposes Final Cash Dividend for the Financial Year Ended June 30, 2020	20-10-02	CI
Ibl Healthcare Limited Reports Earnings Results for the Full Year Ended June 30, 2020	20-10-01	CI
IBL HealthCare Limited Appoints Mufti Zia Ul Islam as Chief Executive	20-06-18	CI
Ibl Healthcare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020	20-04-19	CI
Ibl Healthcare Limited Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-02-27	CI
Ibl Healthcare Limited Reports Earnings Results for the Full Year Ended June 30, 2019	19-10-08	CI
Ibl Healthcare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	19-04-15	CI

Chart IBL HealthCare Limited

Duration

Period

More charts

Company Profile

IBL HealthCare Limited is engaged in marketing, selling and distribution of healthcare products. The Company's product categories include nutrition, health, and wellness, ophthalmic, medical disposables, and pharmaceutical. The nutrition category includes toddlers, baby cereals, medical nutrition, lifestyle nutrition, specialty, and infant formulas. The health and wellness category includes consumer health, and hygiene and safety. The ophthalmic category includes vision care and pharma. The Medical Disposables category consists of renal care, critical care and anesthesia, non-drug, blood transfusion, IV administration, and medical gloves. The Pharmaceutical category consists of various products, such as Seapride, Luxave, Conifa, M-Floxin, Urisolin, Hyplar, Ezcolic, Clariza, and Eprazin. The Company is a subsidiary of The Searle Company Limited and International Brands Limited.

Sector

Drug Retailers

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
IBL HEALTHCARE LIMITED	-4.00%	10.74M
JD HEALTH INTERNATIONAL INC.	-22.12%	12.04B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-24.76%	6.52B
YIFENG PHARMACY CHAIN CO., LTD.	+15.41%	6.44B
MATSUKIYOCOCOKARA & CO.	-9.27%	6.15B
NAHDI MEDICAL COMPANY	-2.48%	4.63B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+60.00%	4.62B
CLICKS GROUP LIMITED	-6.55%	3.93B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-10.60%	3.49B
WELCIA HOLDINGS CO., LTD.	-6.69%	3.05B

Other Drug Retailers